| Code | Description | Claims | Beneficiaries | Total Paid |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
30,768 |
27,526 |
$2.21M |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
24,838 |
21,138 |
$1.81M |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
10,111 |
8,430 |
$686K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
14,604 |
11,966 |
$620K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
3,122 |
2,583 |
$406K |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
4,528 |
3,724 |
$375K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
2,079 |
1,737 |
$316K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
8,304 |
6,624 |
$312K |
| 70450 |
Computed tomography, head or brain; without contrast material |
3,538 |
2,844 |
$306K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
3,997 |
3,646 |
$288K |
| 87636 |
Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B |
6,572 |
6,069 |
$275K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
9,752 |
7,438 |
$198K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
4,024 |
3,459 |
$169K |
| 80053 |
Comprehensive metabolic panel |
25,207 |
20,447 |
$166K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
2,415 |
2,144 |
$156K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
1,596 |
1,306 |
$155K |
| 11042 |
Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm |
2,213 |
946 |
$143K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
3,707 |
3,098 |
$131K |
| 81025 |
|
5,424 |
4,526 |
$108K |
| 87637 |
Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV |
1,789 |
1,696 |
$98K |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
3,389 |
1,569 |
$86K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
6,449 |
5,992 |
$80K |
| 82947 |
|
8,253 |
2,958 |
$72K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
1,238 |
1,018 |
$69K |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
1,859 |
1,098 |
$65K |
| 43239 |
Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple |
619 |
512 |
$57K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
765 |
692 |
$50K |
| 01999 |
|
1,898 |
1,729 |
$46K |
| 76830 |
Ultrasound, transvaginal |
726 |
639 |
$46K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
5,744 |
4,025 |
$46K |
| 71045 |
Radiologic examination, chest; single view |
10,915 |
9,165 |
$44K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
1,822 |
1,506 |
$44K |
| G0378 |
Hospital observation service, per hour |
5,019 |
2,468 |
$43K |
| 71046 |
Radiologic examination, chest; 2 views |
2,636 |
2,203 |
$36K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
1,252 |
1,098 |
$34K |
| 81001 |
|
12,298 |
10,420 |
$27K |
| 76856 |
Ultrasound, pelvic (nonobstetric), real time with image documentation; complete |
730 |
639 |
$23K |
| 73610 |
|
604 |
541 |
$23K |
| 81003 |
|
5,190 |
4,353 |
$22K |
| 87070 |
|
1,085 |
822 |
$19K |
| 73130 |
|
652 |
564 |
$19K |
| 73630 |
|
656 |
574 |
$18K |
| 11043 |
|
150 |
80 |
$18K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
29,883 |
22,747 |
$17K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
12,768 |
9,927 |
$17K |
| 71275 |
Computed tomographic angiography, chest, with contrast material |
199 |
173 |
$17K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
1,189 |
977 |
$14K |
| J7030 |
Infusion, normal saline solution , 1000 cc |
12,592 |
9,110 |
$13K |
| 87186 |
|
2,141 |
1,611 |
$13K |
| 87210 |
|
1,761 |
1,528 |
$12K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
4,420 |
3,677 |
$12K |
| 96376 |
|
3,027 |
1,602 |
$11K |
| 73564 |
|
446 |
365 |
$11K |
| 73030 |
|
357 |
281 |
$11K |
| 72125 |
Computed tomography, cervical spine; without contrast material |
467 |
365 |
$11K |
| 84484 |
|
12,212 |
6,971 |
$11K |
| 45378 |
Colonoscopy, flexible; diagnostic, including collection of specimen(s) |
29 |
27 |
$10K |
| 76705 |
Ultrasound, abdominal, real time with image documentation; limited |
683 |
603 |
$9K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
1,656 |
756 |
$8K |
| 87807 |
|
611 |
571 |
$8K |
| 84703 |
|
9,631 |
8,305 |
$7K |
| 73110 |
|
182 |
159 |
$6K |
| 83690 |
|
9,029 |
7,379 |
$6K |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
8,791 |
6,698 |
$5K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
1,997 |
1,728 |
$5K |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
259 |
209 |
$5K |
| 93971 |
|
341 |
286 |
$5K |
| 80050 |
General health panel |
162 |
148 |
$5K |
| 74019 |
|
223 |
190 |
$4K |
| 86901 |
|
467 |
395 |
$4K |
| 85610 |
|
2,377 |
1,804 |
$4K |
| 12001 |
|
43 |
39 |
$4K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
6,980 |
5,679 |
$3K |
| 99291 |
Critical care, evaluation and management of the critically ill patient, first 30-74 minutes |
31 |
28 |
$3K |
| 84702 |
|
1,933 |
1,578 |
$3K |
| 83735 |
|
3,351 |
2,599 |
$3K |
| 0202U |
Oncology (prostate), multianalyte, gene expression profiling |
13 |
13 |
$3K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
557 |
383 |
$3K |
| J1170 |
Injection, hydromorphone, up to 4 mg |
1,142 |
665 |
$3K |
| 85730 |
|
1,489 |
1,151 |
$3K |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
2,385 |
1,892 |
$3K |
| 87040 |
|
4,370 |
2,038 |
$3K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
1,921 |
1,659 |
$3K |
| 83880 |
|
2,144 |
1,729 |
$3K |
| 76817 |
Ultrasound, pregnant uterus, real time with image documentation, transvaginal |
817 |
685 |
$2K |
| 74018 |
|
75 |
64 |
$2K |
| J7040 |
Infusion, normal saline solution, sterile (500 ml = 1 unit) |
1,164 |
899 |
$2K |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
3,952 |
2,727 |
$2K |
| 82077 |
|
190 |
166 |
$2K |
| 74022 |
|
103 |
82 |
$2K |
| 87077 |
|
1,642 |
1,220 |
$2K |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
1,146 |
947 |
$2K |
| 80061 |
Lipid panel |
573 |
462 |
$1K |
| 76801 |
|
845 |
700 |
$1K |
| 10060 |
|
28 |
25 |
$1K |
| 83605 |
|
2,923 |
2,144 |
$1K |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
1,587 |
1,221 |
$1K |
| J0690 |
Injection, cefazolin sodium, 500 mg |
511 |
357 |
$1K |
| 36415 |
Collection of venous blood by venipuncture |
340 |
242 |
$1K |
| 84443 |
Thyroid stimulating hormone (TSH) |
565 |
454 |
$786.54 |
| 82550 |
|
508 |
419 |
$758.95 |
| 97162 |
|
16 |
13 |
$749.59 |
| 72110 |
|
45 |
38 |
$630.37 |
| J0561 |
Injection, penicillin g benzathine, 100,000 units |
38 |
38 |
$615.96 |
| 78452 |
Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress |
18 |
12 |
$540.07 |
| 73502 |
|
31 |
25 |
$491.58 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
2,111 |
1,499 |
$426.37 |
| J2765 |
Injection, metoclopramide hcl, up to 10 mg |
1,214 |
947 |
$389.44 |
| 73090 |
|
15 |
13 |
$360.58 |
| 87430 |
|
204 |
169 |
$310.63 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
2,128 |
1,749 |
$281.16 |
| 85027 |
|
790 |
582 |
$259.09 |
| 90715 |
|
316 |
257 |
$244.45 |
| 70551 |
Magnetic resonance imaging, brain; without contrast material |
15 |
12 |
$242.12 |
| 85379 |
|
1,076 |
902 |
$213.85 |
| 84132 |
|
83 |
57 |
$195.75 |
| J7050 |
Infusion, normal saline solution, 250 cc |
1,012 |
739 |
$179.79 |
| 87641 |
|
106 |
91 |
$162.96 |
| 0001A |
|
29 |
28 |
$156.80 |
| G1010 |
Clinical decision support mechanism stanson, as defined by the medicare appropriate use criteria program |
55 |
36 |
$133.29 |
| 93017 |
|
19 |
12 |
$115.57 |
| 87801 |
Infectious agent detection by nucleic acid; amplified probe, multiple organisms |
14 |
12 |
$85.70 |
| 86140 |
|
187 |
161 |
$75.39 |
| 93970 |
|
32 |
26 |
$69.35 |
| 86850 |
|
103 |
87 |
$67.42 |
| 83036 |
Hemoglobin; glycosylated (A1C) |
605 |
495 |
$58.86 |
| 82565 |
|
62 |
44 |
$43.07 |
| 97116 |
|
155 |
83 |
$41.76 |
| 88342 |
|
745 |
615 |
$32.46 |
| 86900 |
|
394 |
327 |
$18.29 |
| J1630 |
Injection, haloperidol, up to 5 mg |
266 |
212 |
$6.80 |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
192 |
155 |
$6.72 |
| 73562 |
|
14 |
12 |
$0.00 |
| 84145 |
|
121 |
100 |
$0.00 |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
196 |
167 |
$0.00 |
| J1650 |
Injection, enoxaparin sodium, 10 mg |
77 |
39 |
$0.00 |
| C9113 |
Injection, pantoprazole sodium, per vial |
123 |
92 |
$0.00 |
| 29125 |
|
14 |
12 |
$0.00 |
| J2800 |
Injection, methocarbamol, up to 10 ml |
13 |
12 |
$0.00 |
| J3475 |
Injection, magnesium sulfate, per 500 mg |
34 |
24 |
$0.00 |
| J1644 |
Injection, heparin sodium, per 1000 units |
25 |
12 |
$0.00 |
| 85007 |
|
13 |
13 |
$0.00 |
| 85014 |
|
32 |
25 |
$0.00 |
| A9502 |
Technetium tc-99m tetrofosmin, diagnostic, per study dose |
18 |
12 |
$0.00 |
| 0002A |
|
14 |
13 |
$0.00 |
| 84295 |
|
15 |
12 |
$0.00 |
| 85652 |
|
74 |
64 |
$0.00 |
| J2060 |
Injection, lorazepam, 2 mg |
977 |
748 |
$0.00 |
| J2370 |
Injection, phenylephrine hcl, up to 1 ml |
14 |
12 |
$0.00 |
| J2704 |
Injection, propofol, 10 mg |
152 |
142 |
$0.00 |
| 94760 |
|
388 |
216 |
$0.00 |
| J7512 |
Prednisone, immediate release or delayed release, oral, 1 mg |
231 |
174 |
$0.00 |
| 94762 |
|
20 |
12 |
$0.00 |
| J1815 |
Injection, insulin, per 5 units |
61 |
26 |
$0.00 |
| C1769 |
Guide wire |
17 |
12 |
$0.00 |
| J0131 |
Injection, acetaminophen, not otherwise specified,10 mg |
14 |
13 |
$0.00 |
| 82330 |
|
17 |
14 |
$0.00 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
38 |
18 |
$0.00 |